Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

9.240
-0.290-3.04%
Volume:136.48M
Turnover:1.25B
Market Cap:106.46B
PE:23.30
High:9.440
Open:9.435
Low:9.080
Close:9.530
52wk High:11.203
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:1.04
T/O Rate:1.18%
Dividend:0.34
Dividend Rate:3.64%
EPS(LYR):0.396
ROE:20.90%
ROA:10.70%
PB:2.43
PE(LYR):23.30
PS:2.91

Loading ...

CSPC Pharmaceutical - Crb-701 Receives FDA Clearance for Registrational Trial in Second-Line Oropharyngeal Cancer

THOMSON REUTERS
·
Jul 29

CSPC Pharmaceutical Group Stock Rallies 3.2% in Hong Kong, Outperforms Competitors

Dow Jones
·
Jul 29

Movement Alert|CSPC PHARMA Rises 3.06% in Regular Trading, Mid-Term Profit Alert and Multiple Pipeline Catalysts Continue to Ferment

Market Focus
·
Jul 29

Citi Reaffirms Buy Rating on CSPC Pharma, Sets Price Target at HK$11.50

Deep News
·
Jul 29

Citi: CSPC Pharma's (01093) Interim Profit Alert Far Exceeds Expectations, 'Buy' Rating Reaffirmed

Stock News
·
Jul 28

China's CSPC Pharmaceutical Rises on Robust H1 Earnings Forecast

Reuters
·
Jul 28

CSPC Pharma's Depression Drug Meets Primary Endpoint in Phase 3 Trial

MT Newswires Live
·
Jul 28

CSPC Pharma's Sirolimus Drug Application Accepted in China

MT Newswires Live
·
Jul 28

Movement Alert|CSPC PHARMA Rises 3.86% in Regular Trading, Interim Profit Forecast Surges as Antidepressant Drug Phase III Trial Hits Primary Endpoint

Market Focus
·
Jul 28

Hong Kong Stock Market Preview: Disease Prevention 15th Five-Year Plan Issued, SK Hynix Breaches IPO Price on Wall Street

Stock News
·
Jul 28

Cspc Pharmaceutical Says Phase III Trial of Ha1406 Meets Primary Endpoint

Reuters
·
Jul 27

CSPC PHARMA's Injectable Sirolimus (Albumin-Bound) New Drug Application Accepted by China's NMPA

Stock News
·
Jul 27

CSPC Pharma: Ammoxetine (HA1406) Clears Phase III with Statistically Significant Efficacy in Depression

Bulletin Express
·
Jul 27

CSPC Says China NMPA Accepts Sirolimus Albumin-bound Injection Filing, Grants Priority Review

Reuters
·
Jul 27

CSPC Pharmaceutical - Nmpa Accepts New Drug Application for Sirolimus for Injection (Albumin-Bound)

THOMSON REUTERS
·
Jul 27

CSPC Pharmaceutical - Phase Iii Trial of Ha1406 for Depression Meets Primary Endpoint with Statistical Significance

THOMSON REUTERS
·
Jul 27

CSPC PHARMA (01093) Issues Positive Profit Alert, Expects Significant Interim Net Profit Growth to Around RMB 5.9-6.2 Billion

Stock News
·
Jul 27

CSPC Innovation Pharma, CSPC Pharmaceutical Group Unit, Forecasts H1 Net Profit at 1.18 Billion-1.36 Billion Yuan

Reuters
·
Jul 27

CSPC Pharmaceutical - Expects H1 2026 Profit Attributable to Owners of Rmb5.9 Bln–RMB6.2 Bln

THOMSON REUTERS
·
Jul 27

CSPC Pharmaceutical - Expected Result Due to Significant Increase in Licence Fee Income, Others in Hy

THOMSON REUTERS
·
Jul 27